Key points are not available for this paper at this time.
在轻度阿尔茨海默病患者中，每4周给予400毫克Solanezumab并未显著影响认知衰退。（由礼来公司资助；EXPEDITION3 ClinicalTrials.gov编号，NCT01900665。）
Share your take
Add a clinician perspective alongside expert commentary.
Honig et al. (Thu,) studied this question.